Company: CRNX
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057452
Chunk: 47

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 47
---
 set by the compensation committee in March 2024 and target annual equity awards determined based on market data. It does not include other forms of compensation the executive officers received.

We endeavor to maintain sound executive compensation policies and practices consistent with our executive compensation philosophy. The following highlights some of our executive compensation policies and practices,

<div align='center'>32</div>

which are structured to drive performance and align our executives’ interests with our stockholders’ long-term interests: Principal Elements of Pay Our 2024 executive compensation program generally consisted of three principal components, as further described below. In addition, we provide retirement and benefits plans to executives on the same basis as our other employees and we provide certain other limited remuneration to them. For additional information, please see “Compensation Determination Process” and “Summary Compensation Table” below. In determining each element of compensation for any given year, our compensation committee consider and determine each element individually and then review the resulting total compensation and determine whether it is reasonable and competitive. We do not have a pre-established policy or target for the allocation between either cash and non-cash or short-term and long-term incentive compensation. We believe that the total compensation received by our named executive officers relating to 2024 was appropriate when viewed in light of our corporate achievements during 2024 and the individual performance of our named executive officers.

|                                | Percentage of 2024 Target Compensation(1) |                                          |                                                                                                                                                                                                                     |
|                                | Chief Executive Officer                   | Average of Other NamedExecutive Officers | Description and Purpose                                                                                                                                                                                             |
| Base Salary                    |                                           |                                          | Competitive fixed cash compensation used to attract and retain talented executives.                                                                                                                                 |
| Annual Cash Incentive Awards   |                                           |                                          | Cash incentives designed to reward executive officers for successful corporate performance against board approved annual incentive targets and individual performance toward achieving corporate performance goals. |
| Annual Long-Term Equity Awards |                                           |                                          | Stock option and RSU awards subject to time-based vesting designed to align each executive officer’s incentives with stockholder value creation.                                                                    |

(1) For purposes of the charts in this table, target compensation consists of base salary and target annual incentive awards as set by the compensation committee in March 2024 and target annual equity awards determined based on grant value. It does not include other forms of compensation the executive officers received. Compensation Determination Process

<div align='center'>33</div>

Role of the Compensation Committee The compensation committee of our board of directors develops, reviews and approves each of the elements